The Intelligence from The Economist cover image

Clotting factors: the AstraZeneca vaccine

The Intelligence from The Economist

CHAPTER

Intro

This chapter examines recent analysis by European and British regulators regarding the potential link between blood clots and the AstraZeneca-Oxford COVID vaccine. It discusses the implications of these findings, the cautious stance of health authorities, and the effects on public perception and vaccine rollout.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner